+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Problematic results of a randomized study of neoadjuvant radiochemotherapy of operable esophageal carcinoma

Problematic results of a randomized study of neoadjuvant radiochemotherapy of operable esophageal carcinoma

Strahlentherapie und Onkologie 177(7): 372-373

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 047080681

Download citation: RISBibTeXText

PMID: 11505624

Related references

Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome. Mund- Kiefer- und Gesichtschirurgie 6(2): 117-121, 2002

Neoadjuvant radiochemotherapy in the treatment of esophageal squamous carcinoma:Preliminary results in a series of 15 patients. Chirurgia 98(6): 499-508, 2004

Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. European Journal of Surgical Oncology 30(9): 963-971, 2004

Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?. Journal of Gastroenterology and Hepatology 24(5): 886-895, 2009

MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study. Annals of Surgical Oncology 18(10): 2790-2799, 2011

No improvement of prognosis by neoadjuvant chemotherapy alone in operable esophageal carcinoma. Strahlentherapie und Onkologie 175(5): 251-252, 1999

Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study. Strahlentherapie und Onkologie 171(7): 390-397, 1995

Laparoscopic esophagectomy in palliative treatment of advanced esophageal carcinoma after neoadjuvant radiochemotherapy. Il Giornale di Chirurgia 26(4): 121-129, 2005

Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use?. Diseases of the Esophagus 19(5): 329-334, 2006

Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer : survival advantage in cT2 category by neoadjuvant radiochemotherapy. Strahlentherapie und Onkologie 186(6): 299-306, 2010

Increasing toxicity during neoadjuvant radiochemotherapy as positive prognostic factor for patients with esophageal carcinoma. Diseases of the Esophagus 27(2): 146-151, 2014

Neoadjuvant chemotherapy and concurrent radiochemotherapy for advanced esophageal carcinoma potentially invading adjacent structures. Nihon Geka Gakkai Zasshi 98(9): 761-766, 1997

Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Diseases of the Esophagus 22(6): 477-481, 2009

Possible individualized therapy by early assessment of response during neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma patients by 18-FDG-PET. Journal of Clinical Oncology 24(18_Suppl): 4060-4060, 2016

Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis. World Journal of Surgery 26(5): 584-587, 2002